Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| TSMC | 16.14% | $35.38M | $1.57T | 86.91% | 81 Outperform | |
| ASML Holding NV | 5.44% | $11.92M | €475.49B | 74.46% | 76 Outperform | |
| Infineon Technologies AG | 4.34% | $9.52M | €59.98B | 30.82% | 67 Neutral | |
| Roche Holding AG | 3.14% | $6.88M | CHF294.84B | 46.01% | 73 Outperform | |
| AstraZeneca | 3.08% | $6.75M | $323.92B | 30.42% | 80 Outperform | |
| Novartis AG | 2.96% | $6.49M | CHF242.43B | 28.84% | 80 Outperform | |
| Nestlé SA | 2.56% | $5.61M | CHF198.29B | 10.92% | 71 Outperform | |
| BHP Group Ltd | 1.85% | $4.05M | AU$265.54B | 50.41% | 68 Neutral | |
| SAP SE | 1.81% | $3.97M | €197.41B | -36.18% | 66 Neutral | |
| Schneider Electric | 1.57% | $3.44M | €147.11B | 0.62% | 62 Neutral |